These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 32142869)

  • 1. Impact of Early Prophylactic Cranial Irradiation With Hippocampal Avoidance on Neurocognitive Function in Patients With Limited Disease Small Cell Lung Cancer. A Multicenter Phase 2 Trial (SAKK 15/12).
    Vees H; Caparrotti F; Eboulet EI; Xyrafas A; Fuhrer A; Meier U; Mark M; Elicin O; Aebersold DM; Zwahlen DR; Finazzi T; Allal AS; Putora PM; Martucci F; Rudolf CB; Ribi K;
    Int J Radiat Oncol Biol Phys; 2020 Jun; 107(2):279-287. PubMed ID: 32142869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized Phase III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small-Cell Lung Cancer (PREMER): A GICOR-GOECP-SEOR Study.
    Rodríguez de Dios N; Couñago F; Murcia-Mejía M; Rico-Oses M; Calvo-Crespo P; Samper P; Vallejo C; Luna J; Trueba I; Sotoca A; Cigarral C; Farré N; Manero RM; Durán X; Gispert JD; Sánchez-Benavides G; Rognoni T; Torrente M; Capellades J; Jiménez M; Cabada T; Blanco M; Alonso A; Martínez-San Millán J; Escribano J; González B; López-Guerra JL
    J Clin Oncol; 2021 Oct; 39(28):3118-3127. PubMed ID: 34379442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase 3 Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampus Avoidance in SCLC (NCT01780675).
    Belderbos JSA; De Ruysscher DKM; De Jaeger K; Koppe F; Lambrecht MLF; Lievens YN; Dieleman EMT; Jaspers JPM; Van Meerbeeck JP; Ubbels F; Kwint MH; Kuenen MA; Deprez S; De Ruiter MB; Boogerd W; Sikorska K; Van Tinteren H; Schagen SB
    J Thorac Oncol; 2021 May; 16(5):840-849. PubMed ID: 33545387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment Design and Rationale for a Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for SCLC: PREMER Trial on Behalf of the Oncologic Group for the Study of Lung Cancer/Spanish Radiation Oncology Group-Radiation Oncology Clinical Research Group.
    Rodríguez de Dios N; Couñago F; López JL; Calvo P; Murcia M; Rico M; Vallejo C; Luna J; Trueba I; Cigarral C; Farre N; Manero RM; Durán X; Samper P
    Clin Lung Cancer; 2018 Sep; 19(5):e693-e697. PubMed ID: 29891263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of prophylactic cranial irradiation with hippocampal avoidance in limited stage small cell lung cancer.
    Qu XM; Mishra MV; Bauman GS; Slotman B; Mehta M; Gondi V; Louie AV
    Radiother Oncol; 2017 Mar; 122(3):411-415. PubMed ID: 28109544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective evaluation of whole brain volume loss and neurocognitive decline following hippocampal-sparing prophylactic cranial irradiation for limited-stage small-cell lung cancer.
    Gui C; Chintalapati N; Hales RK; Voong KR; Sair HI; Grimm J; Duhon M; Kleinberg LR; Vannorsdall TD; Redmond KJ
    J Neurooncol; 2019 Sep; 144(2):351-358. PubMed ID: 31302830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study protocol: watchful observation of patients with limited small cell lung cancer instead of the PCI-prospective, multi-center one-arm study.
    Nawrocki S; Sugajska A
    BMC Cancer; 2020 Mar; 20(1):231. PubMed ID: 32188425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-brain irradiation with hippocampal sparing and dose escalation on metastases: neurocognitive testing and biological imaging (HIPPORAD) - a phase II prospective randomized multicenter trial (NOA-14, ARO 2015-3, DKTK-ROG).
    Grosu AL; Frings L; Bentsalo I; Oehlke O; Brenner F; Bilger A; Fennell JT; Rothe T; Schneider-Fuchs S; Graf E; Schmoor C; Beck J; Becker G; Bock M; Egger K; Urbach H; Lahmann C; Popp I
    BMC Cancer; 2020 Jun; 20(1):532. PubMed ID: 32513138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hippocampal avoidance prophylactic cranial irradiation (HA-PCI) for small cell lung cancer reduces hippocampal atrophy compared to conventional PCI.
    de Ruiter MB; Groot PFC; Deprez S; Pullens P; Sunaert S; de Ruysscher D; Schagen SB; Belderbos J
    Neuro Oncol; 2023 Jan; 25(1):167-176. PubMed ID: 35640975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive Interaction between Prophylactic Cranial Irradiation and Maintenance Sunitinib for Untreated Extensive-Stage Small Cell Lung Cancer Patients After Standard Chemotherapy: A Secondary Analysis of CALGB 30504 (ALLIANCE).
    Salama JK; Gu L; Wang X; Pang HH; Bogart JA; Crawford J; Schild SE; Vokes EE; Ready NE
    J Thorac Oncol; 2016 Mar; 11(3):361-9. PubMed ID: 26723241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective Study of Hippocampal-Sparing Prophylactic Cranial Irradiation in Limited-Stage Small Cell Lung Cancer.
    Redmond KJ; Hales RK; Anderson-Keightly H; Zhou XC; Kummerlowe M; Sair HI; Duhon M; Kleinberg L; Rosner GL; Vannorsdall T
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):603-611. PubMed ID: 28581401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis.
    Sun A; Bae K; Gore EM; Movsas B; Wong SJ; Meyers CA; Bonner JA; Schild SE; Gaspar LE; Bogart JA; Werner-Wasik M; Choy H
    J Clin Oncol; 2011 Jan; 29(3):279-86. PubMed ID: 21135267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms: results of an international Phase III randomized controlled trial by the EORTC Radiation Oncology and Lung Cancer Groups.
    Slotman BJ; Mauer ME; Bottomley A; Faivre-Finn C; Kramer GW; Rankin EM; Snee M; Hatton M; Postmus PE; Collette L; Senan S
    J Clin Oncol; 2009 Jan; 27(1):78-84. PubMed ID: 19047288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracranial failure after hippocampal-avoidance prophylactic cranial irradiation in limited-stage small-cell lung cancer patients.
    Cho Y; Lee J; Lee IJ; Kim JW; Baek JG; Jung DM; Cho BC; Hong MH; Kim HR; Lee CG; Yoon HI
    Sci Rep; 2021 Apr; 11(1):7435. PubMed ID: 33795826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer.
    Wolfson AH; Bae K; Komaki R; Meyers C; Movsas B; Le Pechoux C; Werner-Wasik M; Videtic GM; Garces YI; Choy H
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):77-84. PubMed ID: 20800380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of hippocampal metastases in small cell lung cancer patients at presentation and after cranial irradiation: a safety profile study for hippocampal sparing during prophylactic or therapeutic cranial irradiation.
    Kundapur V; Ellchuk T; Ahmed S; Gondi V
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):781-6. PubMed ID: 25752392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of prophylactic cranial irradiation in patients with small cell lung cancer in the modern era of baseline magnetic resonance imaging of the brain.
    Held MK; Hansen O; Schytte T; Hansen KH; Bahij R; Nielsen M; Nielsen TB; Jeppesen SS
    Acta Oncol; 2022 Feb; 61(2):185-192. PubMed ID: 34583620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic Cranial Irradiation in Patients With High-Risk Metastatic Non-Small Cell Lung Cancer: Quality of Life and Neurocognitive Analysis of a Randomized Phase II Study.
    Maldonado F; Gonzalez-Ling A; Oñate-Ocaña LF; Cabrera-Miranda LA; Zatarain-Barrón ZL; Turcott JG; Flores-Estrada D; Lozano-Ruiz F; Cacho-Díaz B; Arrieta O
    Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):81-92. PubMed ID: 33915217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of prophylactic cranial irradiation on survival in elderly patients with limited-stage small cell lung cancer.
    Eaton BR; Kim S; Marcus DM; Prabhu R; Chen Z; Ramalingam SS; Curran WJ; Higgins KA
    Cancer; 2013 Nov; 119(21):3753-60. PubMed ID: 23921891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of prophylactic cranial irradiation for elderly patients with limited-disease small-cell lung cancer: inverse probability of treatment weighting using propensity score.
    Kim TG; Pyo H; Ahn YC; Noh JM; Oh D
    J Radiat Res; 2019 Oct; 60(5):630-638. PubMed ID: 31165148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.